Stocks-SNDX-Syndax Pharmaceuticals Inc

SNDX Syndax Pharmaceuticals Inc

22.10 0 (0%)
Marked lukketForsinkede priser fra NASDAQ i USD
Handel
Handel

Syndax Pharmaceuticals Inc pris

0% Seneste uge
Markedsværdi
1.78B
Interval dag
22.01
-
22.51
Interval 52 uger
11.04
-
26.34
Volumen (3 M)
1.53M
Forhold mellem pris og indtjening
-8.55
Indtægt
-

Syndax Pharmaceuticals Inc Seneste nyt

Se alle
Opslået opslag
Cancer Treatment Stocks
Novartis to acquire cancer-focused MorphoSys for $2.9 billion. 💊 Drugmaker $NVS (Novartis ADR) said it will acquire $MOR.DE (MorphoSys), a developer of cancer treatments, for €2.7 billion, adding a promising rare bone-marrow cancer treatment candidate to its portfolio. German biotech firm's shares... Vis Oversæt
Synes godt om KommentarDel
Vis flere kommentarer2 af 3
null
.
Top Diskussioner
Manfre118
Guarda il grafico di $SNDX (Syndax Pharmaceuticals Inc) che ho condiviso Oversæt
Lorenzo Riccio
Arjun Gaur
Grandmasters of Work 1. Creativity Garry Kasparov lost to IBM’s Deep Blue computer in 1997. The press saw it as the turning point where man lost his edge to machine. Kasparov saw it differently. Not because he needed to justify his loss, but because he recognised the nuance of what computers were... Vis Oversæt
MarketUpdates
Redigeret
$SNDX (Syndax Pharmaceuticals Inc) Kvartal 4 2023-indtjeningsrapport forventes at blive offentliggjort
27
FEB
Rapporter
Q4, 2023-regnskab forventes
Giv mig besked
SNDX
SNDX
Syndax Pharmaceuticals Inc
22.10
0
(0%)
Handl
MarketUpdates
$SNDX (Syndax Pharmaceuticals Inc) Q4 2023 earnings report is expected to be released Oversæt

SNDX Kommende begivenheder

27
FEB
Regnskab
Q1 2024
Efter markedets lukning

Analytikerprognose

Konsensus
Stærkt køb
Prismål
30.50

ESG: En ny kilde til indsigt

Få indsigt i en virksomheds bæredygtighed ved hjælp af ESG-score (miljø, social og ledelse).
0
100
51
Mellem
Branche 
Gns. 43 
31
Miljø
45
Social
70
Ledelse

Andre købte også